Notably, our data demonstrated that the antitumour activity we observed in vivo correlated with the induction of histone acetylation, a marker of HDAC-Is activity, as well as with a reduction in the markers of proliferation and induction of apoptosis on tumour xenografts. This evidence concerns the gene HDAC9 and neoplasm.